Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valentina Trimarco

Showing results (31-40 of 144) with videos related to

Pageof 15
Sort By:
Journal of Hypertension|October 14, 2004
The Glu27 allele of the beta2 adrenergic receptor increases the risk of cardiac hypertrophy in hypertensionGuido Iaccarino, Francesca Lanni, Ersilia Cipolletta, et al.
Seminars in Thrombosis and Hemostasis|May 4, 2018
Anticancer Drug-Related Nonvalvular Atrial Fibrillation: Challenges in Management and Antithrombotic StrategiesAntonella Tufano, Maurizio Galderisi, Luca Esposito, et al.
Eclinicalmedicine|September 19, 2022
Corrigendum to "Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis."Giuseppe Fiorentino, Antonietta Coppola, Raffaele Izzo, et al.
Eclinicalmedicine|September 15, 2021
Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysisGiuseppe Fiorentino, Antonietta Coppola, Raffaele Izzo, et al.
Journal of Hypertension|May 23, 2002
Increased basal nitric oxide release despite enhanced free radical production in hypertensionAngelo Maffei, Roberta Poulet, Carmine Vecchione, et al.
Annals of Hematology|December 21, 2022
Persistent splenomegaly due to littoral cell angiomatosis in venetoclax-induced undetectable minimal residual disease of chronic lymphocytic leukemiaAlessandro Cellini, Federico Scarmozzino, Alberto Friziero, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|July 23, 2013
Antioxidant effects of resveratrol in cardiovascular, cerebral and metabolic diseasesAlbino Carrizzo, Maurizio Forte, Antonio Damato, et al.
Frontiers in Cardiovascular Medicine|August 15, 2022
Determinants of improvement of left ventricular mechano-energetic efficiency in hypertensive patientsMaria Lembo, Valentina Trimarco, Maria Virginia Manzi, et al.
Frontiers in Cardiovascular Medicine|May 2, 2022
L-Arginine Improves Cognitive Impairment in Hypertensive Frail Older AdultsPasquale Mone, Antonella Pansini, Stanislovas S Jankauskas, et al.
Journal of Human Hypertension|May 2, 2018
Difficult-to-control hypertension: identification of clinical predictors and use of ICT-based integrated care to facilitate blood pressure controlValeria Visco, Rosa Finelli, Antonietta Valeria Pascale, et al.
Pageof 15

Showing results (31-40 of 144) with videos related to

Sort By:
Pageof 15
Journal of Hypertension|October 14, 2004
The Glu27 allele of the beta2 adrenergic receptor increases the risk of cardiac hypertrophy in hypertensionGuido Iaccarino, Francesca Lanni, Ersilia Cipolletta, et al.
Seminars in Thrombosis and Hemostasis|May 4, 2018
Anticancer Drug-Related Nonvalvular Atrial Fibrillation: Challenges in Management and Antithrombotic StrategiesAntonella Tufano, Maurizio Galderisi, Luca Esposito, et al.
Eclinicalmedicine|September 19, 2022
Corrigendum to "Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis."Giuseppe Fiorentino, Antonietta Coppola, Raffaele Izzo, et al.
Eclinicalmedicine|September 15, 2021
Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysisGiuseppe Fiorentino, Antonietta Coppola, Raffaele Izzo, et al.
Journal of Hypertension|May 23, 2002
Increased basal nitric oxide release despite enhanced free radical production in hypertensionAngelo Maffei, Roberta Poulet, Carmine Vecchione, et al.
Annals of Hematology|December 21, 2022
Persistent splenomegaly due to littoral cell angiomatosis in venetoclax-induced undetectable minimal residual disease of chronic lymphocytic leukemiaAlessandro Cellini, Federico Scarmozzino, Alberto Friziero, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|July 23, 2013
Antioxidant effects of resveratrol in cardiovascular, cerebral and metabolic diseasesAlbino Carrizzo, Maurizio Forte, Antonio Damato, et al.
Frontiers in Cardiovascular Medicine|August 15, 2022
Determinants of improvement of left ventricular mechano-energetic efficiency in hypertensive patientsMaria Lembo, Valentina Trimarco, Maria Virginia Manzi, et al.
Frontiers in Cardiovascular Medicine|May 2, 2022
L-Arginine Improves Cognitive Impairment in Hypertensive Frail Older AdultsPasquale Mone, Antonella Pansini, Stanislovas S Jankauskas, et al.
Journal of Human Hypertension|May 2, 2018
Difficult-to-control hypertension: identification of clinical predictors and use of ICT-based integrated care to facilitate blood pressure controlValeria Visco, Rosa Finelli, Antonietta Valeria Pascale, et al.
Pageof 15